Document -

Novus Scientific announces inclusion of the first patient in a pivotal clinical trial on the use of TIGR® Matrix Surgical Mesh in ventral hernia repair.

The study is a double-blinded multicenter randomized controlled trial where a long-term absorbable mesh, TIGR® Matrix, will be evaluated for use in surgical repair of primary and secondary ventral hernias. The control group will receive a standard light-weight polypropylene mesh.
  • License: © All rights reserved
    The Content may only be used by Mynewsdesk. It is thus not permissible for anyone else to download, copy, distribute or otherwise use the Content (other than for private use to the extent permitted by law).
  • File format: .doc

Contacts

Jan Hermansson

Press contact Global Marketing Manager +46703778337

Related content

Novus Scientific announces inclusion of the first patient in a pivotal clinical trial on the use of TIGR® Matrix Surgical Mesh in ventral hernia repair.

The study is a double-blinded multicenter randomized controlled trial where a long-term absorbable mesh, TIGR® Matrix, will be evaluated for use in surgical repair of primary and secondary ventral hernias. The control group will receive a standard light-weight polypropylene mesh.